Andrew G Messenger
Overview
Explore the profile of Andrew G Messenger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Messenger A, Asfour L, Harries M
Am J Clin Dermatol
. 2024 Dec;
26(2):155-174.
PMID: 39699852
In this review, we discuss recent developments in our understanding of frontal fibrosing alopecia, a disease that has become increasingly common and widespread since its first description in 1994. An...
2.
British Association of Dermatologists living guideline for managing people with alopecia areata 2024
Harries M, Ascott A, Asfour L, Farrant P, Hale G, Holmes S, et al.
Br J Dermatol
. 2024 Oct;
192(2):190-205.
PMID: 39432739
No abstract available.
3.
Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study
Thompson A, Tziotzios C, Nesnas J, Randall R, Czachorowski M, Messenger A
Br J Dermatol
. 2024 Aug;
191(6):924-935.
PMID: 39104082
Background: Alopecia areata (AA) is an immune-mediated form of hair loss that can occur at any age, often with a significant mental health burden. Objectives: We aimed to provide estimates...
4.
Bootsma N, Zucchelli F, Asfour L, Messenger A
J Eur Acad Dermatol Venereol
. 2024 Feb;
38(8):e737-e738.
PMID: 38375766
No abstract available.
5.
Redmond L, Limbu S, Farjo B, Messenger A, Higgins C
Exp Dermatol
. 2023 May;
32(7):1174-1181.
PMID: 37237288
Male pattern hair loss (MPHL), also referred to as male androgenetic alopecia (AGA) is the most common type of non-scarring progressive hair loss, with 80% of men suffering from this...
6.
Messenger A, Harries M, Macbeth A, Chiu W, Holmes S, Tziotzios C, et al.
Clin Exp Dermatol
. 2023 Jan;
48(4):332-338.
PMID: 36702574
Background: It is not known whether alopecia areata (AA) is associated with a greater or reduced risk for infection. Aim: We undertook a population-based study exploring associations between AA and...
7.
Holmes S, Harries M, Macbeth A, Chiu W, de Lusignan S, Messenger A, et al.
Clin Exp Dermatol
. 2023 Jan;
48(4):325-331.
PMID: 36689337
Background: Alopecia areata (AA) has features of both autoimmune and atopic pathogenesis, but information on the risk of people with AA developing autoimmune and atopic conditions is limited. Objective: To...
8.
Macbeth A, Holmes S, Harries M, Chiu W, Tziotzios C, de Lusignan S, et al.
Br J Dermatol
. 2022 Feb;
187(1):73-81.
PMID: 35157313
Background: Alopecia areata (AA) is a common cause of nonscarring hair loss that can have a profound psychological impact. Objectives: To assess the co-occurrence of depression and anxiety in adults...
9.
Harries M, Macbeth A, Holmes S, Thompson A, Chiu W, Gallardo W, et al.
BMJ Open
. 2021 Nov;
11(11):e045718.
PMID: 34785540
Introduction: Alopecia areata (AA) is a common cause of immune-mediated non-scarring hair loss. Links between AA and common mental health, autoimmune and atopic conditions, and common infections have previously been...
10.
Hamed F, Astrand A, Bertolini M, Rossi A, Maleki-Dizaji A, Messenger A, et al.
PLoS One
. 2019 Sep;
14(9):e0222473.
PMID: 31498852
[This corrects the article DOI: 10.1371/journal.pone.0210308.].